Psychedelic remedy for PTSD with MDMA faces misconduct hurdle : Brief Wave : NPR

Later this yr, the FDA plans to resolve whether or not MDMA can be utilized to deal with PTSD

Eva Almqvist/Getty Pictures

conceal caption

toggle caption

Eva Almqvist/Getty Pictures

Later this yr, the FDA plans to resolve whether or not MDMA can be utilized to deal with PTSD

Eva Almqvist/Getty Pictures

Folks with post-traumatic stress dysfunction (PTSD) might quickly have a brand new remedy possibility: MDMA.

MDMA is the chemical compound discovered within the drug generally known as ecstasy. In August, the Meals and Drug Administration plans to resolve whether or not MDMA might be accredited for market primarily based on years of analysis. However critical allegations of analysis misconduct might derail the approval timeline.

NPR science reporter Will Stone talks to host Emily Kwong in regards to the scientific trials on MDMA-assisted remedy analysis and a latest report questioning the validity of the outcomes.

Learn Will’s full story right here.

Wish to hear us cowl extra tales about well being analysis? E mail us at shortwave@npr.org.

Take heed to Brief Wave on Spotify, Apple Podcasts and Google Podcasts.

Pay attention to each episode of Brief Wave sponsor-free and help our work at NPR by signing up for Brief Wave+ at plus.npr.org/shortwave.

This episode was produced by Berly McCoy, edited by Amina Khan and truth checked by Will Stone. Josh Newell was the audio engineer.